Boehringer Ingelheim and Eli Lilly & Company launch type 2 diabetes educational game, "Complications Combat"
For Non-U.S. and Non-UK media
Boehringer Ingelheim responds to FDA warning letter
Wireless Pill Bottle Wins Healthcare Innovation World Cup
Phase III results: tiotropium* Respimat® effective in symptomatic asthma patients despite at least ICS†/LABA‡ independent of their age, allergic status, smoking status and bronchodilator response
For Media outside the U.S., Canada and UK
Change in the Board of Managing Directors at Boehringer Ingelheim
